Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01036568 · ClinicalTrials.gov registry record

Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia

A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
121
Enrollment target

NCT01036568 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 121 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01036568 has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
121 participants
Enrollment target

Study Summary

Background: \- Eye tracking, the ability to focus on and follow a moving target with the eyes, is often difficult for people who have schizophrenia. Research has shown that first-degree relatives of people with schizophrenia, such as parents and siblings, also tend to have difficulty with smooth eye movement and eye tracking. Researchers are interested in using functional magnetic resonance imaging (fMRI) to study brain activity during eye tracking tests in order to better understand the effect that schizophrenia has on brain function. Objectives: \- To study eye-tracking and eye-tracking impairments in people with and without schizophrenia. Eligibility: \- Individuals between 18 and 62 years of age in one of three groups: (1) patients who have been diagnosed with schizophrenia/schizoaffective disorder, (2) first-degree relatives of patients in group 1, and (3) healthy volunteers with no family history of psychosis. Design: * The study will involve two visits, one screening session and one testing session. Each session will take about 3 hours. * Participants will be asked to avoid consuming alcohol and restrict consumption of caffeine before the start of the study. Participants will provide urine and breath samples to be tested for chemicals that may interfere with the study. * Participants will visit the clinical center the morning of the day before the scanning session to provide blood and urine samples as required. Participants will return and be admitted for an overnight stay later that afternoon or evening. * During the screening session, participants will provide a medical and psychological history, provide blood samples, and learn the eye movement tasks they will do during the scanning session. * During the scanning session, participants will have an fMRI scan. During the scan, they will perform eye movement tasks that involve following moving light targets on a screen, and will also perform other tasks that test the ability to think and pay attention.

Trial Details

FieldValue
Enrollment Target 121 participants
Start Date 2006-02-14
Est. Completion 2013-03-07

What the Registry Record Tells You About NCT01036568

The ClinicalTrials.gov registry entry for NCT01036568 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 121 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01036568 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01036568 about?

NCT01036568 is a clinical study titled "Neuroimaging Studies of Neurophysiological Phenotypes in Schizophrenia". Background: \- Eye tracking, the ability to focus on and follow a moving target with the eyes, is often difficult for people who have schizophrenia. Research has shown that first-degree relatives of people with schizophrenia, such as parents and siblings, also tend to have difficulty with smooth ey...

What is the current status of trial NCT01036568?

This trial is currently completed. The enrollment target is 121 participants. The study started on 2006-02-14. Estimated completion is 2013-03-07.

Who is sponsoring clinical trial NCT01036568?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.